Investor Relations
Complete overview of the company's information
Corporate Governance
Chairman
Roberto AnzanelloCEO
Livia FogliaBoard Member
Oscar Pischeddu Massimiliano AlfieriIndependent Board Member
Andrea Di DioChairman
Massimo D'AgostinoStanding Auditor
Paolo LombardoStanding Auditor
Agostino GaldiAlternate Auditor
Francesco TomasiAlternate Auditor
Luigi Borrelli
Sustainability
Information for shareholders
- Facsimile form for the bank
-
08/05/2025
Health Italia S.p.A. distributes a second extraordinary dividend in kind through the assignment of Rebirth S.p.A. shares
Year | N. of Shares | Nominal Value | Share Capital | Dividend Unit | Monte Dividendi | Exchange |
---|---|---|---|---|---|---|
2025 | 189.780 | N.A. | € 18.978.097,00 | n. 29 shares of the subsidiary Rebirth SpA for each Health Italia SpA share owned | n. 5,503,620 shares of the subsidiary Rebirth SpA (total amount € 9,906,516) | Mercato Euronext Growth Milan |
2024 | 189.780 | € 100,00 | € 18.978.097,00 | N.A. | N.A. | Mercato Euronext Growth Milan |
2023 | 18.978.097 | € 1,00 | € 18.978.097,00 | N.A. | N.A. | Mercato Euronext Growth Milan |
2022 | 18.978.097 | € 1,00 | € 18.978.097,00 | N.A. | N.A. | Mercato Euronext Growth Milan |
2021 | 18.978.097 | € 1,00 | € 18.978.097,00 | N.A. | N.A. | Mercato Euronext Growth Milan |
2020 | 18.978.097 | € 1,00 | € 18.978.097,00 | N.A. | N.A. | Mercato AIM |
2019 | 14.324.956 | € 1,00 | € 14.324.956,00 | An ordinary share for every 100 shares and € 0.025 for each ordinary share | € 354.552 e n. 141.820 ordinary shares | Mercato AIM |
2018 | 14.324.956 | € 1,00 | € 14.324.956,00 | € 0,082 | € 1.173.808,00 | Mercato AIM |
2017 | 12.371.530 | € 1,00 | € 12.371.530,00 | € 0,081 | € 1.001.266,00 | Mercato AIM |
2016 | 11.245.580 | € 1,00 | € 11.245.580,00 | 0,00€ | 0,00€ | Unlisted |
Shareholding | Number of shares | % Share of ordinary capital |
---|---|---|
Sorgiva Holding S.p.A. | 47.391 | 24,97% |
Mutua MBA Società di Mutuo Soccorso SCpA | 25.769 | 13,58% |
PFH S.r.l. | 17.482 | 9,21 % |
Amara Life Holdings Ltd | 15.342 | 8,08 % |
Own actions * | 321 | 0,17 % |
Market | 83.475 | 43,99% |
A shareholders' agreement is in place between shareholders representing 29.37% of the share capital, as announced in a press release dated 03.26.2024.
Updated on 07.01.2025.
From 1th July 2019 Health Italia stocks are negotiable with a minimum units lot.
There is no record of other shareholders apart from those listed above owning a share in the capital exceeding 5% that have notified Consob and Health Italia S.p.A. pursuant to art. 117 of Consob Regulation no. 11971/99 concerning the notification obligations for the relevant holdings.
Health Italia has met the requirements for the qualification of issuer with financial instruments distributed between the public to a significant extent pursuant to art. 2-bis of Consob Regulation no. 11971 of 1999. This qualification is effective starting from the 2020 financial year.
- the identity of the Significant Shareholders involved;
- the date on which Health Italia S.p.A. has been informed;
- the date on which the Substantial Change of the investments took place;
- the nature and extent of the participation of the Significant Shareholder in the transaction.
- Minutes of Ordinary Assembly 04.17.2025
- List of Health Italia Board of Directors candidates
- Explanatory report Ordinary Shareholders' Meeting 04/17/2025
- Extended Notice of Call Ordinary Shareholders' Meeting 04/17/2025
- Reduced Notice of Call Ordinary Shareholders' Meeting 04/17/2025
- Delegation pursuant to art. 135-novies TUF
- Delegation pursuant to art. 135-undecies TUF
- Banca Profilo - Health Italia company update - October 3, 2024
- Banca Profilo - Health Italia company update - 27 March 2024
- GBC - AG - Research Report (update) 09 November 2023 - EN
- GBC - AG - Research Report (update) 09 November 2023 - DE
- Banca Profilo - Health Italia company update - 27 September 2023
- GBC - AG - Research Report Initial Coverage 29 august 2023 - DE
- GBC - AG - Research Report Initial Coverage 29 august 2023 - EN
- Banca Profilo - Health Italia Initial Coverage - 04 august 2023
- Mediobanca - Well positioned to deliver healthy growth - 05 October 2021
- Mediobanca - Looking to keep the growth path found in 2020 - 09 June 2021
- Mediobanca - Profitability step-up needed to unlock upside - 10 July 2020
- Mediobanca - Moving further steps in nutraceutics - 7 Nov 2019
- Equity Research - FY18 Update - 4 Oct 2019
- Equity Research - H1 2018 Update - 11 Dic 2018
- Mediobanca - Initiation of Coverage - 28 Feb 2018
- Equity Research - Initiation of Coverage - 23 Mag 2017
- Equity Research - IPO - Integrated Health Plans and Services - 24 Nov 2016
- Health Italia consolidated half-yearly financial statements as of 30.06.2024
- Health Italia consolidated half-yearly financial statements as of 30.06.2023
- Health Italia consolidated half-year financial statements at 30.06.2022
- Health Italia consolidated half-year financial statements at 30.06.2021
- Consolidated half-yearly financial report as of June 30, 2020 with KPMG report
- Consolidated half-yearly financial report as of June 30, 2019 with KPMG report
- Interim Consolidated Financial Statements at 30/06/2018 with KPMG report
- Consolidated Interim Financial Statements at 30/06/2018
- Consolidated Half Year Report at 30/06/2018
- Consolidated Half Year Report at 30/06/2017
- Interim consolidated financial statements at 30/06/2016
- Financial statements and consolidated financial statements as of 31/12/2024 with BDO Reports
- Financial statements and consolidated financial statements as at 31/12/2023 with reports by KPMG
- Financial statements and consolidated financial statements as at 31/12/2022 with reports by KPMG
- Financial statements and consolidated financial statements as at 31/12/2021 with reports by KPMG
- Financial statements and consolidated financial statements as at 31/12/2020 with reports by KPMG
- Financial statements and consolidated financial statements as at 31/12/2019 with KPMG reports
- Consolidated financial statements as at 31/12/2018 with KPMG report
- Consolidated financial statements as at 31/12/2018
- Financial statements as at 31/12/2018 with KPMG report
- Financial statements as at 31/12/2018
- Consolidated financial statement 31/12/2017
- Financial statement 31/12/2017
- Consolidated Financial Statements at 31/12/2016
- Financial statements at 31/12/2016
- Aggregate balance sheet at 31/12/2015
DATES | EVENTS |
---|---|
March 13, 2025 | Board of Directors – approval of the draft financial statement and consolidated financial statements as of 31 December 2024 |
April 17, 2025 | Shareholders’ Meeting – approval of the financial statement and presentation of the consolidated financial statement as of 31 December 2024 |
September 22-26, 2025 | Board of Directors – approval of the half-year report as of 30 June 2025 |
Livia Foglia
investor@healthitalia.comSpecialist

Euronext Growth Advisor

Corporate Broker

Auditor

Legal Advisor

Legal Advisor

Investor e Media Relations

Admission document
- are resident in Italy and who are not domiciled or in any case currently staying in the United States, Australia, Japan, Canada or any other country where the circulation of the Admission Document and/or of any such information that requires the approval of the local authorities or is in violation of local rules or regulations (“Other Countries”);
- they are not a "U.S. Person" as defined in Regulation S of the United States Securities Act of 1933, as subsequently amended.
Any "U.S. Person" as defined in the aforementioned paragraph is precluded from any access to this section of the Website, temporary or permanent download and saving of the Admission Document or any other information contained in this section of the Website. The information contained in this section of the website cannot be copied or forwarded. For no reason and under no circumstances, are you allowed to circulate, directly or through third parties, the Admission Document and any other information contained in this section of the website outside of Italy, particularly in the United States, Australia, Japan, Canada or Other Countries, or distribute the Admission Document to non-resident Italian citizens.
Regulation S of the United States Securities Act of 1933, as subsequently amended, defines a "U.S. Person" as:
- any physical person residing in the United States;
- "partnerships" and "corporations" established and organized according to the law in force in the United States;
- any property whose administrators or managers are a "U.S. Person";
- trusts whose trustee is a "U.S. Person";
- any agency, branch or subsidiary of a subject having its headquarters in the United States;
- non-discretionary accounts;
- other similar accounts (except properties or trusts), managed or administered confidentially on behalf of or for the benefit of a "U.S. Person";
- "partnerships" and "corporations" if (i) set up and organised according to the laws of any foreign jurisdiction; and (ii) constituted by a "U.S. Person" with the principal aim of investing in unlisted securities under the United States Securities Act of 1933, as subsequently amended, unless they are constituted or organized and owned by accredited investors (as defined in Rule 501 (a) of United States Securities Act of 1933) that are not natural persons, properties or trusts
To access this section of the website, the Admission Document and any other information contained in the following pages, I declare under my sole responsibility that I am resident in Italy and not domiciled or presently staying in the United States, Australia, Japan, Canada or Other Countries and that I am not a "U.S. Person" as defined in Regulation S of the United States Securities Act of 1933, as subsequently amended.
I confirm I have read and agree to the above Terms and Conditions
Health is the greatest strength of a civilised people
Keep in touch with us
Enter your email here to receive news from the world of Health Italia